Akanda has regained compliance with nasdaq's minimum bid price requirement

London, united kingdom--(newsfile corp. - june 14, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, announced that it has received a letter (the "compliance notice") from the listing qualifications department of the nasdaq stock market inc. ("nasdaq") dated june 7, 2024, informing the company that it has regained compliance with nasdaq listing rule 5550(a)(2) (the "minimum bid price requirement"). as previously announced, akanda received a notification letter from nasdaq dated july 3, 2023 indicating that its common shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the listing rules of nasdaq.
AKAN Ratings Summary
AKAN Quant Ranking